Sermorelin
Growth Hormone Research
Research Use Only — Not for Human or Veterinarian Administration

Sermorelin

Sermorelin is a GHRH(1-29) analogue that stimulates pituitary GH release in endocrine research models.

5mg$52.00
View only
10mg$60.00
View only
View Certificate of AnalysisThird-party HPLC lab report · opens PDF

Mechanism of Action

Binds GHRH receptors on somatotroph cells, triggering pulsatile GH release. The No-DAC form provides a shorter-acting profile suitable for protocols requiring discrete GH pulses.

Research Applications

  • GH pulse dynamics research
  • GHRH receptor binding assays
  • Pituitary somatotroph function studies

Specifications

sequenceModified GHRH(1-29) analogue
molecular Weight~3367 Da
appearanceWhite lyophilized powder

Reconstitution (Laboratory)

Reconstitute with bacteriostatic water. GH secretagogues are sensitive — use gentle swirling.

Storage & Handling

Lyophilized: 2–8 °C. Reconstituted: refrigerate; use promptly per protocol.

Quality Assurance

Every lot undergoes independent third-party HPLC purity analysis, mass spectrometry identity confirmation, and endotoxin testing (<0.5 EU/mg). Certificate of Analysis (COA) is stored against the SKU lot number and available through your research account portal.

Sources & References

  1. 1.Teichman SL, et al. CJC-1295 pharmacokinetics in healthy adults. J Clin Endocrinol Metab. 2006. · PubMed →
  2. 2.Ionescu M, Frohman LA. Pulsatile GH secretion in humans. Endocr Rev. 2006. · PubMed →